文献速递主动脉外科冠心病外科

急性A型主动脉夹层中不同适应证冠状动脉旁路移植的差异结局

Differential Outcomes of Indication-Specific Coronary Artery Bypass Grafting in Acute Type A Aortic Dissection.
PubMed 文献 · Eur J Cardiothorac Surg · 2022-01-01

单中心回顾性研究纳入2010至2018年972例急性A型主动脉夹层急诊手术患者,按是否行CABG及适应证(冠状动脉夹层、冠心病、停循环后心衰)分层。CABG组30天死亡率显著高于非CABG组(15.1% vs 5.6%,P<.001),其中HFD组达50%;HFD增加30天死亡风险(OR 3.90,95%CI 1.07-14.22),但长期生存不劣于其他亚组;CAD组长期生存最低(P=.002)。

要点

  • CABG组30天死亡率显著高于非CABG组(15.1% vs 5.6%,P<.001)。
  • 停循环后心衰行CABG增加30天死亡风险(OR 3.90,95%CI 1.07-14.22)。
  • 冠心病适应证CABG不影响30天死亡率,但长期生存最低(P=.002)。

核心结论

  • 停循环后心衰行CABG显著增加30天死亡风险但不影响长期死亡率。
  • 冠心病适应证CABG不影响30天死亡率但降低此后的长期生存。

研究设计与样本

  • 单中心回顾性研究,纳入2010至2018年阜外医院972例急性A型主动脉夹层急诊手术患者(平均年龄47岁)。
  • 按是否行CABG分组,CABG组再按适应证分为冠状动脉夹层、冠心病、停循环后心衰三个亚组。

主要发现

  • CABG组30天死亡率为15.1%(18/119),非CABG组为5.6%(48/853),P<.001。
  • 冠状动脉夹层亚组30天死亡率为8.1%(5/62),冠心病亚组为5.7%(2/35),停循环后心衰亚组为50%(11/22)。
  • 多变量logistic回归显示停循环后心衰行CABG增加30天死亡率(OR 3.90,95%CI 1.07-14.22)。
  • 总体10年生存率为82.0%; landmark分析显示停循环后心衰患者晚期生存不劣于其他亚组,而冠心病患者晚期生存率最低(P=.002)。

临床怎么用

  • 对急性A型主动脉夹层需行CABG者,应识别停循环后心衰这一高危适应证以评估30天死亡风险。
  • 冠心病适应证CABG患者需关注长期生存,加强远期随访管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to analyse how different indications for coronary artery bypass grafting (CABG) impact early mortality and long-term outcomes in patients with acute type A aortic dissection at a single high-volume centre. METHODS: Between 2010 and 2018, patients diagnosed with acute type A aortic dissection who underwent emergency surgical repair at Fuwai Hospital were included. Patients were categorized by presence of concomitant CABG. Within this group, patients were further stratified by indication: coronary artery dissection, coronary artery disease (CAD), and heart failure after declamping (HFD). RESULTS: A total of 972 patients (mean age 47 years) were included. The 30-day mortality was significantly higher in the CABG group [18/119 (15.1%) vs 48/853 (5.6%); P < .001], with rates of 8.1% (5/62) for coronary artery dissection, 5.7% (2/35) for CAD, and 50% (11/22) for HFD. Multivariable logistic regression analysis revealed that bypass grafting for HFD increased 30-day mortality (odds ratio, 3.90; 95% confidence interval, 1.07-14.22). Overall, 10-year survival was 82.0%. Landmark analysis revealed that HFD patients had non-inferior late survival compared to other subgroups, whereas patients with CAD exhibited the lowest late survival rate (P = .002). CONCLUSIONS: CABG for HFD significantly increases the risk of 30-day mortality but not long-term mortality. Bypass grafting for CAD does not affect 30-day mortality but decreases long-term survival beyond this period compared to patients without bypass grafting.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Zhang K, Zhou C, Gao S, et al. Differential Outcomes of Indication-Specific Coronary Artery Bypass Grafting in Acute Type A Aortic Dissection. Eur J Cardiothorac Surg. 2022. PMID: 40758469. doi:10.1093/ejcts/ezaf270

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。